Safety and efficacy of a peripheral intravenous bolus of Licartin for the treatment of advanced hepatocellular carcinoma

@inproceedings{Dai2013SafetyAE,
  title={Safety and efficacy of a peripheral intravenous bolus of Licartin for the treatment of advanced hepatocellular carcinoma},
  author={Dong Dai and Wengui Xu and Jianjing Liu and Liang Zhu and Xiang Zhu and Xiaoying Ma},
  booktitle={Experimental and therapeutic medicine},
  year={2013}
}
The aim of the present study was to examine the safety and efficacy of a peripheral intravenous bolus of Licartin for the treatment of advanced hepatocellular carcinoma (HCC), and to explore the clinical value of this treatment. Clinical data from Tianjin Medical University Cancer Institute and Hospital (Tianjin, China) were analyzed. Thirty-three patients… CONTINUE READING